cDNA, genomic cloning, and gene expression analysis of mouse PSP94 (prostate secretory protein of 94 amino acids)

DNA and Cell Biology

Volumn 18, Issue 1, 1999, Pages 11-26

  Xuan, Jim W ^a,e   Kwong, Joseph ^b   Chan, Franky L ^b   Ricci, Mariantonietta ^a   Imasato, Yushi ^c   Sakai, Hideki ^c   Fong, Guo H ^a   Panchal, Chandra ^d   Chin, Joseph L ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c NAGASAKI UNIVERSITY   (Japan)

^d Procyon Biopharma Inc   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; AMINO ACID; COMPLEMENTARY DNA; DNA FRAGMENT; MESSENGER RNA; SECRETORY PROTEIN;

ANIMAL TISSUE; ARTICLE; DNA SEQUENCE; GENE; GENE EXPRESSION; GENE STRUCTURE; IN SITU HYBRIDIZATION; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RAT; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; CYSTEINE; DNA, COMPLEMENTARY; EVOLUTION, MOLECULAR; GENE EXPRESSION; GENOME; HUMANS; IN SITU HYBRIDIZATION; MALE; MICE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PEPTIDES; PROSTATE; PROSTATIC SECRETORY PROTEINS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEMINAL PLASMA PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

EID: 0032937801     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999315583     Document Type: Article

References (64)

1. ABRAHAMSSON, P.-A., LILJA, H., FALKMER, S., and WADSTROM, L.B. (1988). Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 12, 39-46.
2. AKIYAMA, K., YOSHIOKA, Y., SCHMID, K., OFFNER, G.D., TROXLER, R.F., TSUNDA, R., and HARA, M. (1985). The amino acid sequence of human β-microseminoprotein. Biochim. Biophys. Acta 829, 288-294.
3. CARTER, D., and RESNICK, M.I. (1982). High resolution analysis of human prostatic fluid by two-dimensional electrophoresis. Prostate 3, 27-33.
4. +-ATPase. Biochem. Biophys. Res. Commun. 218, 623-628.
5. DOCTOR, V.M., SHETH, A.R., SIMHA, M.M., ARBATTI, N.J., AAVERI, J.P., and SHETH, N.A. (1986). Studies on immunocytochemical localization of inhibin-like material in human prostate tissue: comparison of its distribution in normal, benign and malignant prostates. Br. J. Cancer 53, 547-554.
6. DUBE, J.Y., FRENETTE, G., PAQUIN, R., CHAPDELAINE, P., TREMBLAY, J., TREMBLAY, R.R., LAZURE, C., SEIDAH, N., and CHRETIEN, M. (1987). Isolation from human seminal plasma of an abundant 16-kDa protein originating from the prostate, its identification with a 94-residue peptide originally described as β-inhibin. J. Androl. 8, 182-189.
7. FERNLUND, P., GRANBERG, L., and ROEPSTORF, P. (1994). Amino acid sequence of β-microseminoprotein from porcine seminal plasma. Arch. Biochem. Biophys. 309, 70-76.
8. FERNLUND, P., GRANBERG, L., and LARSON, I. (1996). Cloning of β-microseminoprotein of the rat: a rapidly evolving mucosal surface protein. Arch. Biochem. Biophys. 334, 73-82.
9. FOSTER, B.A., GINGRICH, J.R., KWON, E.D., MADIAS, C., and GREENBERG, N.M. (1997). Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res. 57, 3325-3330.
10. GARDE, S., SHETH, A., POTER, A.T., and PIENTA, K.J. (1993a). Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and vivo. Prostate 22, 225-233.
11. GARDE, S.V., SHETH, A.R., PORTER, A.T., and PIENTA, K.J. (1993b). A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett. 70, 159-166.
12. GINGRICH, J.R., BARRIOS, R.J., MORTON, R.A., BOYCE, B.F., DEMAYO, F.J., FINEGOLD, M.J., ANGELOPOULOU, R., ROSEN, J.M., and GREENBERG, N.M. (1996). Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56, 4096-4102.
13. GOJOBORI, T., MORIYAMA, E.T., and KIMURA, M. (1990). Statistical methods for estimating sequence divergence. Methods Enzymol. 183, 531-550.
14. GORDON, W.L., LIU, W.K., AKIYAMA, K., TSUDA, R., HARA, M., SCHMID, K., and WARD, D. (1987). Beta-microseminoprotein (β-MSP) is not an inhibin. Biol. Reprod. 36, 829-835.
15. GREEN, C.B., LIU, W.Y., and KWOK, S.C.M. (1990). Cloning and nucleotide sequence analysis of the human β-microseminoprotein gene. Biochem. Biophys. Res. Commun. 167, 1184-1190.
16. GREENBERG, N.M., DEMAYO, F., FINEGOLD, M.J., MEDINA, D., TILLEY, W.D., ASPINALL, J.O., CUNHA, G.R., DONJACOUR, A.A., MATUSIK, R.J., and ROSEN, J.M. (1995). Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci USA 92, 3439-3443.
17. HO, S.M., and YU, M. (1993). Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostate of Nobel rats. Cancer Res. 53, 528-532.
18. HO, S.M., LEAV, I., MERK, F.B., YU, M., KWAN, P.W., and ZIAR, J. (1995). Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta. Lab. Invest. 73, 356-365.
19. HUANG, C.L., LIANG, H.M., BRASSIL, D., SCHELLHAMMER, P.F., ROZZEL, M., NEWHALL, K., BECKETT, M.L., and WRIGHT G.L. JR. (1992). Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serum. Clin. Chem. 38, 817-823.
20. HUANG, C.L., BRASSIL, D., ROZZEL, M., SCHELLHAMMER, P.F., and WRIGHT JR, G.L. (1993). Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma. Prostate 23, 201-212.
21. HYAKUTAKE, H., SAKAI, H., YOGI, Y., TSUDA, R., MINAMI, Y., YUSHITA, Y., KANETAKE, H., NAKAZONO, I., and SAITO, Y. (1993). β-Microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinoma. Prostate 22, 347-355.
22. ISAACS, J.T. (1987). Development and characteristics of the available animal model systems for the study of prostatic cancer. In Current Concepts and Approaches to the Study of Prostate Cancer, vol. 239. D.S. Coffey, N. Bruchovsky, W.A. Gardner, M.I. Resnick, and J.P. Karr, eds. (Alan R. Liss, New York), pp. 513-576.
23. KOHAN, S., FROYSA, B., CEDERLUND, E., FAIRWELL, T., LERNER, R., JOHANSSON, J., KHAN, S., RITZEN, M., JORNVALL, H., CEKAN, S., and DICZFALUSY, E. (1986). Peptides of postulated inhibin activity: lack of in vitro inhibin activity of a 94-residue peptide isolated from human seminal plasma, and of a synthetic replicate of its C-terminal 28-residue segment. FEBS Lett. 199, 242-248.
24. 35S- and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization. Histochemistry 98, 217-228.
25. LEAV, I., HO, S.M., OFNER, P., MERK, F.B., KWAN, P.W., and DAMASSA, D. (1988). Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Nobel rats. J. Natl. Cancer. Inst. 80, 1045-1053.
26. LEAV, I., MERK, F.B., KWAN, P.W.L., and HO, S.M. (1989). Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Nobel rats. Prostate 15, 23-40.
27. LEE, C. (1987). Gross dissection of three lobes of the rat prostate. In Current Concepts and Approaches to the Study of Prostate Cancer. D.S. Coffey, N. Bruchovsky, W.A. Gardner Jr., M. Resnick, and J.P. Karr, eds. (Alan R. Liss, New York) pp. 577-582.
28. LILJA, H. (1985). A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest. 76, 1899-1903.
29. LOKESHWAR, B.L., HURKADLI, K.S., SHETH, A.R., and BLOCK, N.L. (1993). Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor. Cancer Res. 53, 4855-4859.
30. MAEDA, N., KAMADA, M., DAITOH, T., AONO, T., FUTAKI, S., LIANG, Z.G., and KOIDE, S.S. (1993). Immunoglobulin binding factor in human seminal plasma: immunological function. Arch. Androl. 31, 31-36.
31. MAHALE, S.D., SHETH, A.R., and IYER, K.S.N. (1993). Studies on the carboxyl terminal peptides of human plasma inhibin (HSPI): chemical synthesis and in vivo biological activity of the disulfide loop peptide 67-94 of HSPI. Int. J. Peptide Res. 42, 132-137.
32. MBIKAY, M., LINARD, C.G., SIROIS, F., LAZURE, C., SEIDAH, N.G., and CHRETIEN, M. (1988). Tissue-specific expression of the prostatic secretory protein PSP94 in cyanomolgus monkey (Macaca fascicularis). Cell. Mol. Biol. 34, 387-398.
33. MBIKAY, M., NOLET, S., FOURNIER, S., BENJANNET, S., CHAPDELAINE, P., PARADIS, G., DUBE, J.Y., TREMBLAY, R., LAZURE, C., SEIDAH, N.S., and CHRETIEN, M. (1987). Molecular cloning and sequence of the cDNA for a 94-amino-acid seminal plasma protein secreted by the human prostate. DNA 6, 23-29.
34. MUNDEL, S.D., and SHETH, N.A. (1993). Suppression of DNA synthesis and induction of apoptosis in rat prostate by human seminal plasma inhibin (HSPI). Cell. Biol. Int. 17, 587-594.
35. NEI, M. (1987): Molecular Evolutionary Genetics. (Columbia University Press, New York)
36. NOLET, S., MBIKAY, M., and CHRETIEN, M. (1991a). Prostatic secretory protein PSP94: gene organization and promoter sequence in Rhesus monkey and human. Biochim. Biophys. Acta 1089, 247-249.
37. NOLET, S., ST-LOUIS, D., MBIKAY, M., and CHRETIEN, M. (1991b). Rapid evolution of prostatic protein PSP94 suggested by sequence divergence between Rhesus monkey and human cDNA. Genomics 9, 775-777.
38. OCHIAI, Y., INAZAWA, J., UEYAMA, H., and OHKUBO, I. (1995). Human gene for beta-microseminoprotein: its promoter structure and chromosomal localization. J. Biochem. 117, 346-352.
39. SAKAI, H., TSUSAKI, T., KANDA, S., KOJI, T., XUAN, J.W., and SAITO, Y. (1998). Prognostic significance of β-microseminoprotein mRNA expression in prostate cancer. Prostate (in press)
40. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989); Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
41. SHETH, A.R., TENI, T.R., and SHETH, N.A. (1988). Human prostatic inhibin. In Progress in Endocrinology. H. Imura, ed. (Elsevier Science Publishers B.V., Amsterdam), pp. 301-306.
42. SHETH, N.A., DOCTOR, V.M., SAMPAT, M.B., GARDE, S.V., ARBATTI, N.J., and SHETH, A.R. (1987a). Inhibin-like material - an immunohistological marker for prostatic origin of metastases. Cancer Lett. 36, 93-98.
43. SHETH, A.R., GARDE, S.V., HURKADLI, K.S., and SHAH, N.A. (1991). Prostate-A 'non-classical' source of FSH and inhibin: are these hormones involved in the etiopathology of prostatic tumours? In Perspectives in Primate Reproductive Biology. N.R. Moudgal, K. Yoshinaga, A.J. Rao, and P.R. Adiga, eds. (Wiley Eastern Limited, New Dehli, India) pp. 235-241.
44. SHETH, N.A., VANAGE, G.R., HURKADLI, K.S., and SHETH, A.R. (1987b). Prostate - an extragonadal source of inhibin: demonstration of inhibin in normal benign, and malignant human prostate and rat prostate by bioassay, radioimmunoassay, immunocytochemical localization and biosynthesis. In Inhibin, vol. 1. A.R. Sheth, ed. (CRC Press, Boca Raton, FL) pp. 109-128.
45. SUGIMURA, Y., CUNHA, G.R., and DONJACOUR, A.A. (1986). Morphogenesis of ductal networks in the mouse prostate. Biol. Reprod. 34, 961-971.
46. SZECSI, P.B., and LILJA, H. (1993). Gastricsin-mediated proteolytic degradation of human seminal fluid proteins at pH levels found in the human vagina. J. Androl. 14, 351-358.
47. TANAKA, T., ITAHANA, K., ANDOH, N., TAKEYA, T., and SATO, E. (1996). Expression of prosatate secretory protein (PSP)-like protein in porcine corpus luteum: isolation and characterization of a new gene encoding PSP94-like protein. Mol. Reprod. Dev. 42, 149-156.
48. TENI, T.R., SHETH, A.R., KAMATH, M.R., and SHETH, N.A. (1988). Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate. Cancer Lett. 43, 9-14.
49. TENI, T.R., BANDIVDEKAR, A.H., SHETH, A.R., and SHETH, N.A. (1989). Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay. Clin. Chem. 35, 1376-1379.
50. TREMBLAY, J., FRENETTE, G., TREMBLAY, R.R., DUPONT, A., THABET, M., and DUBE, J.Y. (1987). Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypotrophy or prostate cancer. Prostate 10, 235-243.
51. TSURUSAKI, T., KOJI, T., SAKAI, H., KANETAKE, H., NAKANE, P.K., and SAITO, Y. (1998). Cellular expression of beta-microseminoprotein (β-MSP) mRNA and its protein in untreated prostate cancer. Prostate 35, 109-116.
52. ULVSBACK, M., LINDSTROM, C., WEIBER, H., ABRAHAMSSON, P.A., LILJA, H., and LUNDWALL, A. (1989). Molecular cloning of a small prostate protein, known as β-microseminoprotein. PSP94 or β-inhibin, and demonstration of transcripts in non-genital tissues. Biochem. Biophys. Res. Commun. 164, 1310-1315.
53. ULVSBACK, M., SPURR, N.K., and LUNDWALL, A. (1991). Assignment of the human gene for β-microseminoprotein (MSMB) to chromosome 10 and demonstration of related genes in other vertebrates. Genomics 11, 920-924.
54. VAN DER KAMMER, H., JURINCIC-WINKLER, C., HORLBECK, R., KLIPPEL, K.F., PIXBERG, H.U., and SCHEIT, K.H. (1993). The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostate tumor. Urol. Res. 21, 227-233.
55. VAN DER KAMMER, H., SCHEIT, K.H., WEIDNER, W., and COOPER, T.G. (1991). The evaluation of markers of prostatic function. Urol. Res. 19, 343-347.
56. VAZE, A.Y., THAKUR, A.N., and SHETH, A.R. (1979). Development of a radio immunoassay for human seminal plasma inhibin. J. Reprod. Fertil. suppl. 26, 135-146.
57. WEIBER, H., ANDERSON, C., MURNE, A., RANNEVIK, G., LINDSTROM, C. LILJA, H., and FERNLUND, P. (1990). β-Microseminoprotein is not a prostate-specific protein. Am. J. Pathol. 137, 593-603.
58. XUAN, J.W., CHIN, J.L., GUO, Y., CHAMBERS, A.F., FINKELMAN, M.A., and CLARKE, M.W. (1995). Alternative splicing of PSP94 (prostate secretory protein of 94 amino acid) mRNA in prostate tissue. Oncogene 11, 1041-1047.
59. XUAN, J.W., KOWALSKI, J., CHAMBERS, A.F., and DENHARDT, D.T. (1994). A human promyelocyte mRNA transiently induced by TPA is homologous to the yeast IPP isomerase. Genomics 20, 129-131.
60. XUAN, J.W., WU, D., GUO, Y., FRASER, J., and CHIN, J. (1996). Recombinant PSP94 (prostate secretory protein of 94 amino acids) demonstrates similar linear epitope structure as natural PSP94 protein. J. Cell. Biochem 63, 61-74.
61. XUAN, J.W., WU, D., GUO, Y., GARDE, S., SHUM, D., MBIKAY, M., ZHONG, R., and CHIN, J.L. (1997a). Molecular cloning and gene expression analysis of PSP94 (prostate secretory protein of 94 amino acids) in primates. DNA Cell Biol. 16, 627-638.
62. XUAN, J.W., WU, D., GUO, Y., GARDE, S.V., BAIJAL-GUPTA, M., and CHIN, J.L. (1997b). Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids) I: immuno-dominant and immuno-recessive area. J. Cell. Biochem. 65, 172-185.
63. XUAN, J.W., WU, D., GUO, Y., HUANG, C.L., WRIGHT, G.L. JR., and CHIN, J.L. (1997c). Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids) II: epitope mapping by monoclonal antibodies. J. Cell. Biochem. 65, 185-197.
64. YU, M., LEAV, B.A., LEAV, I., MERK, F.B., WOLFE, H.J., and HO, S.M. (1993). Early alterations in rat protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats. Lab. Invest. 68, 33-44.